Cilian Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 5

Cilian General Information

Description

Provider of biotechnology products for the treatment of cancer and pancreatic diseases. The company offers sub-unit vaccines for the treatment of seasonal and pandemic flu as well as ciliate lipase for exocrine pancreatic insufficiency.

Contact Information

Website
www.cilian.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Johann-Krane-Weg 42
  • 48149 Munster
  • Germany
+49 0251 000000
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Johann-Krane-Weg 42
  • 48149 Munster
  • Germany
+49 0251 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cilian Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cilian‘s full profile, request access.

Request a free trial

Cilian Patents

Cilian Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3212187-A1 Purification of proteins Pending 09-Apr-2021 0000000000
AU-2022254851-A1 Purification of proteins Pending 09-Apr-2021 0000000000
EP-4320142-A1 Purification of proteins Pending 09-Apr-2021 0000000000
US-20240191275-A1 Purification of proteins Pending 09-Apr-2021 0000000000
EP-4172325-A1 New lipase enzyme Pending 24-Jun-2020 C12N9/20
To view Cilian’s complete patent history, request access »

Cilian Executive Team (4)

Name Title Board Seat
Christian Scheiner Chief Executive Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Cilian Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cilian Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cilian‘s full profile, request access.

Request a free trial

Cilian FAQs

  • When was Cilian founded?

    Cilian was founded in 2001.

  • Who is the founder of Cilian?

    Marcus Hartmann Ph.D is the founder of Cilian.

  • Who is the CEO of Cilian?

    Christian Scheiner is the CEO of Cilian.

  • Where is Cilian headquartered?

    Cilian is headquartered in Munster, Germany.

  • What is the size of Cilian?

    Cilian has 30 total employees.

  • What industry is Cilian in?

    Cilian’s primary industry is Biotechnology.

  • Is Cilian a private or public company?

    Cilian is a Private company.

  • What is Cilian’s current revenue?

    The current revenue for Cilian is 00000.

  • How much funding has Cilian raised over time?

    Cilian has raised $6.13M.

  • Who are Cilian’s investors?

    AAC Capital, Bioceros, Brightlands Venture Partners, and Newmex Ventures have invested in Cilian.

  • When was Cilian acquired?

    Cilian was acquired on 12-Jan-2011.

  • Who acquired Cilian?

    Cilian was acquired by Lonza Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »